Tirzepatide is a dual incretin agonist targeting GLP‑1 and GIP receptors. It improves glycemic control, reduces appetite, and promotes weight…
Semaglutide is a synthetic GLP‑1 receptor agonist used for type 2 diabetes and obesity management. It improves glycemic control, reduces…
Retatrutide is a novel investigational peptide drug acting as a triple agonist of GLP‑1, GIP, and glucagon receptors. It is…
Cagrilintide is a long‑acting synthetic amylin analog under investigation for obesity and metabolic disorders. It targets amylin receptors (AMYR1–3) to…